Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis Pain, Quality of Life Improved With Internet Intervention

Juvenile Idiopathic Arthritis Pain, Quality of Life Improved With Internet Intervention

By

Teenagers with juvenile idiopathic arthritis and their parents enjoyed participating in an internet-based intervention designed to improve accessibility and disease self-management.

Juvenile Idiopathic Arthritis: Risk Factors for Infection of Biologic Therapy

Juvenile Idiopathic Arthritis: Risk Factors for Infection of Biologic Therapy

By

Patients with juvenile idiopathic arthritis receiving biologic therapy have high rates of serious infections.

Emerging Technology to Help Treat Juvenile Idiopathic Arthritis

Emerging Technology to Help Treat Juvenile Idiopathic Arthritis

By

Technological advances can be helpful in juvenile idiopathic arthritis and are particularly well suited to younger people in general, who are more comfortable with device technologies and more likely to adopt them.

Serum Vitamin D Level Linked to Cardiovascular Risks in Juvenile Idiopathic Arthritis

Serum Vitamin D Level Linked to Cardiovascular Risks in Juvenile Idiopathic Arthritis

By

In patients with juvenile idiopathic arthritis, levels of serum vitamin D are closely related to cholesterol levels and other risk factors for cardiovascular disease.

Juvenile Idiopathic Arthritis Treatment With TNFIs Linked With Higher Infection Risk

Juvenile Idiopathic Arthritis Treatment With TNFIs Linked With Higher Infection Risk

By

Children with juvenile idiopathic arthritis using anti-TNFIs have a significantly higher risk for infection compared with children using DMARDs.

Sign Up for Free e-Newsletters